[Treatment of cerebral circulation disorders].
D000367:Age Factors; D000368:Aged; D001274:Atmospheric Pressure; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004983:Ethanolamines / Q000627:therapeutic use*; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D004983:Ethanolamines; D009539:Nicotinic Acids; D013566:Sympathomimetics; D007294:Inositol
Zur Behandlung der zerebralen Durchblutungsstörungen.